 |
|
Pneumocystis carinii Pneumonia in Patients With Primary Brain Tumors
John W. Henson, MD;
Jai K. Jalaj;
Russell W. Walker, MD;
Diane E. Stover, MD;
Anna O. S. Fels, MD
Arch Neurol. 1991;48(4):406-409.
Abstract
• All histologically documented episodes of Pneumocystis carinii pneumonia in adult patients with primary brain tumors treated at Memorial Sloan-Kettering Cancer Center, New York, NY, since 1981, were retrospectively reviewed. Pneumocystis carinii pneumonia was histologically documented 11 times in 10 patients. During the same 8-year interval, approximately 587 adults were seen at the center for a brain tumor, 90% of whom received ongoing therapy. Therefore, in at least 1.7% (10/587) of our patients with brain tumors, P carinii pneumonia developed. The median duration of dexamethasone therapy at the onset of P carinii pneumonia symptoms was 2.75 months. Symptoms began during tapering of steroid therapy in eight episodes. Bronchoscopy was diagnostic in the eight cases in which it was performed. Four episodes (40%) were fatal. Trimethoprim-sulfamethoxazole prophylaxis may be indicated in some patients with brain tumors, especially during tapering of steroid therapy.
Author Affiliations
From the Department of Neurology (Drs Henson and Walker) and the Pulmonary Division (Drs Jalaj, Stover, and Fels), Memorial Sloan-Kettering Cancer Center, New York, NY. Dr Jalaj is now in private practice in Fishkill, NY.
Footnotes
Accepted for publication October 18, 1990.
Reprint requests to Department of Neurology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021 (Dr Walker).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Genotypic variation in Pneumocystis jirovecii isolates in Britain
Miller et al.
Thorax 2005;60:679-682.
ABSTRACT
| FULL TEXT
Prevention of Infection Due to Pneumocystis spp. in Human Immunodeficiency Virus-Negative Immunocompromised Patients
Rodriguez and Fishman
Clin. Microbiol. Rev. 2004;17:770-782.
ABSTRACT
| FULL TEXT
Asymptomatic carriage of Pneumocystis jiroveci in subjects undergoing bronchoscopy: a prospective study
Maskell et al.
Thorax 2003;58:594-597.
ABSTRACT
| FULL TEXT
T-Cell Immunodeficiency Following Cytotoxic Antineoplastic Therapy: A Review
Mackall
The Oncologist 1999;4:370-378.
ABSTRACT
| FULL TEXT
Pneumocystis carinii Pneumonia in Patients Without AIDS, 1980 Through 1993: An Analysis of 78 Cases
Arend et al.
Arch Intern Med 1995;155:2436-2441.
ABSTRACT
Pneumocystis carinii Pneumonia Without Acquired Immunodeficiency Syndrome: More Patients, Same Risk
Sepkowitz et al.
Arch Intern Med 1995;155:1125-1128.
ABSTRACT
Pneumocystis carinii Pneumonia Associated With Solid Ectopic Corticotropin-Producing Tumors
McQuillen and Sugar
Arch Neurol 1992;49:1012-1012.
ABSTRACT
Pneumocystis carinii Pneumonia Among Patients Without AIDS at a Cancer Hospital
Sepkowitz et al.
JAMA 1992;267:832-837.
ABSTRACT
|
